JP2006514940A5 - - Google Patents

Download PDF

Info

Publication number
JP2006514940A5
JP2006514940A5 JP2004557232A JP2004557232A JP2006514940A5 JP 2006514940 A5 JP2006514940 A5 JP 2006514940A5 JP 2004557232 A JP2004557232 A JP 2004557232A JP 2004557232 A JP2004557232 A JP 2004557232A JP 2006514940 A5 JP2006514940 A5 JP 2006514940A5
Authority
JP
Japan
Prior art keywords
phenyl
methyl
methoxy
tert
butyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004557232A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006514940A (ja
JP4926402B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/037104 external-priority patent/WO2004050642A1/en
Publication of JP2006514940A publication Critical patent/JP2006514940A/ja
Publication of JP2006514940A5 publication Critical patent/JP2006514940A5/ja
Application granted granted Critical
Publication of JP4926402B2 publication Critical patent/JP4926402B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2004557232A 2002-11-27 2003-11-20 サイトカインインヒビターとしての1,2,3−トリアゾールアミド誘導体 Expired - Lifetime JP4926402B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43051902P 2002-11-27 2002-11-27
US60/430,519 2002-11-27
PCT/US2003/037104 WO2004050642A1 (en) 2002-11-27 2003-11-20 1, 2, 3- triazole amide derivatives as cytokine inhibitors

Publications (3)

Publication Number Publication Date
JP2006514940A JP2006514940A (ja) 2006-05-18
JP2006514940A5 true JP2006514940A5 (enExample) 2007-01-18
JP4926402B2 JP4926402B2 (ja) 2012-05-09

Family

ID=32469486

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004557232A Expired - Lifetime JP4926402B2 (ja) 2002-11-27 2003-11-20 サイトカインインヒビターとしての1,2,3−トリアゾールアミド誘導体

Country Status (9)

Country Link
US (2) US7166628B2 (enExample)
EP (1) EP1567507B1 (enExample)
JP (1) JP4926402B2 (enExample)
AT (1) ATE329909T1 (enExample)
AU (1) AU2003294388A1 (enExample)
CA (1) CA2507184C (enExample)
DE (1) DE60306193T2 (enExample)
ES (1) ES2265596T3 (enExample)
WO (1) WO2004050642A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7591994B2 (en) * 2002-12-13 2009-09-22 Immunomedics, Inc. Camptothecin-binding moiety conjugates
US7511042B2 (en) 2003-12-03 2009-03-31 Boehringer Ingelheim Pharmaceuticals, Inc. Triazole compounds
US7485657B2 (en) 2004-05-12 2009-02-03 Boehringer Ingelheim Pharmaceuticals, Inc. Anti-cytokine heterocyclic compounds
WO2006109846A1 (ja) * 2005-04-06 2006-10-19 Takeda Pharmaceutical Company Limited トリアゾール誘導体およびその用途
WO2006124283A1 (en) * 2005-05-12 2006-11-23 Boehringer Ingelheim International, Gmbh Bis-amination of aryl halides
ES2353724T3 (es) * 2005-07-25 2011-03-04 F. Hoffmann-La Roche Ag Derivados de triazol substitutidos y su uso como antagonistas del receptor neuroquinina 3.
PE20080401A1 (es) * 2006-07-07 2008-06-23 Boehringer Ingelheim Int DERIVADOS DE HETEROARIL-FENIL SUSTITUIDOS COMO INHIBIDORES DE B-Raf-QUINASAS
CL2008001943A1 (es) 2007-07-02 2009-09-11 Boehringer Ingelheim Int Compuestos derivados de fenil-triazol, inhibidores de enzimas de señales especificas que participan del control de la proliferacion celular; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar cancer, infecciones, enfermedades inflamatorias y autoinmunes.
CA2692379A1 (en) * 2007-07-02 2009-01-08 Boehringer Ingelheim International Gmbh Antiproliferative compounds based on 5-membered heterocycles
TW201014860A (en) 2008-09-08 2010-04-16 Boehringer Ingelheim Int New chemical compounds
EP2350052B1 (en) 2008-09-29 2014-08-13 Boehringer Ingelheim International GmbH Antiproliferative compounds
EP2398797B1 (en) 2009-02-17 2013-11-06 Boehringer Ingelheim International GmbH Pyrimido[5,4-d]pyrimidine derivatives for the inhibition of tyrosine kinases
JP2011057661A (ja) * 2009-08-14 2011-03-24 Bayer Cropscience Ag 殺虫性カルボキサミド類
EP2552907B1 (en) 2010-03-26 2014-10-22 Boehringer Ingelheim International GmbH Pyridyltriazoles
US9290507B2 (en) 2010-03-26 2016-03-22 Boehringer Ingelheim International Gmbh B-RAF kinase inhibitors
US8710055B2 (en) 2010-12-21 2014-04-29 Boehringer Ingelheim International Gmbh Triazolylphenyl sulfonamides as serine/threonine kinase inhibitors
US8889684B2 (en) 2011-02-02 2014-11-18 Boehringer Ingelheim International Gmbh Azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
EP2925746A1 (en) * 2012-12-03 2015-10-07 F. Hoffmann-La Roche AG Substituted triazole and imidazole compounds

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4302051A1 (de) 1993-01-26 1994-07-28 Thomae Gmbh Dr K 5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
FR2732967B1 (fr) 1995-04-11 1997-07-04 Sanofi Sa 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
ATE254105T1 (de) 1998-09-25 2003-11-15 Astrazeneca Ab Benzamid-derivate und ihre verwendung als cytokine inhibitoren
PT1123287E (pt) 1998-10-23 2003-12-31 Dow Agrosciences Llc 1-(piridil substituido)-1,2,4-triazoles insecticidas
UA73492C2 (en) * 1999-01-19 2005-08-15 Aromatic heterocyclic compounds as antiinflammatory agents
US20010044445A1 (en) * 1999-04-08 2001-11-22 Bamaung Nwe Y. Azole inhibitors of cytokine production
US7297708B2 (en) 2001-09-06 2007-11-20 Bristol-Myers Squibb Company Heteroaromatic substituted cyclopropane as corticotropin releasing hormone ligands
CA2462289C (en) 2001-10-04 2010-02-23 Nicholas D. Cosford Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5
EP1434579B1 (en) 2001-10-09 2011-06-08 Amgen Inc. Imidazole derivatives as antiinflammatory agents
AU2003209388A1 (en) 2002-01-29 2003-09-02 Merck And Co., Inc. Substituted imidazoles as cannabinoid receptor modulators
US7511042B2 (en) * 2003-12-03 2009-03-31 Boehringer Ingelheim Pharmaceuticals, Inc. Triazole compounds
US7485657B2 (en) * 2004-05-12 2009-02-03 Boehringer Ingelheim Pharmaceuticals, Inc. Anti-cytokine heterocyclic compounds

Similar Documents

Publication Publication Date Title
ES2327940T3 (es) 3-(4-heterociclil-1,2,3-triazol-1-il)-n-aril-benzamidas en calidad de inhibidores de la produccion de citocinas para el tratamiento de enfermedades inflamatorias cronicas.
RU2757457C2 (ru) Пирролопиримидины в качестве потенциаторов мвтр
US7582630B2 (en) Pyradazine compounds as GSK-3 inhibitors
US7183306B2 (en) Pyrazole derivatives
US10308605B2 (en) Proton pump inhibitors
ES2566772T3 (es) Inhibidores de la quinasa c-fms
JP5659166B2 (ja) ピリダジノン化合物
US20090239845A1 (en) Pyrazole compounds as prostaglandin receptors ligands
KR101071438B1 (ko) 카나비노이드 수용체 길항제로서의피라졸로[1,5-a]피리미딘 화합물
CA2507184A1 (en) 1, 2, 3- triazole amide derivatives as cytokine inhibitors
JP5379690B2 (ja) 5員複素環化合物
US20080153810A1 (en) Indazole derivatives useful as melanin concentrating receptor ligands
TW201240663A (en) Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
CN101084195A (zh) 作为5-ht2a血清素受体调节剂适用于治疗与其相关的病症的3-苯基-吡唑衍生物
CN1203589A (zh) 新的化合物
JP2007536231A5 (enExample)
JP2005530730A5 (enExample)
JP2007513167A5 (enExample)
JP2006522784A (ja) 炎症疾患の治療でp38MAPキナーゼインヒビターとして使用の5‐アミノ‐2‐カルボニルチオフェン誘導体
JP2007537255A5 (enExample)
CN104024250A (zh) 作为痕量胺相关受体(taar)的杂环衍生物
BG65369B1 (bg) Дифенилетерни съединения, приложими в терапията
WO1999025695A1 (en) 5-arylpyrazole compounds
US20090012299A1 (en) Pyrazolo-pyridinone compounds and methods of use thereof
JPH072788A (ja) 新規な経口活性を有するアゾール誘導体